On Jan 18, 2022 Ori Biotech closed a Series B round and raised $100,000,000 from Amadeus Capital Partners, Chimera Investment, Delin Ventures, Northpond Ventures, Novalis LifeSciences, Octopus Ventures, Puhua Capital, featuring lead investors Chimera Investment, Novalis LifeSciences, Puhua Capital.

About the company: Ori Biotech is located at United Kingdom, Europe.
“An innovator in Cell and Gene Therapy with a proprietary, flexible manufacturing platform that can enable widespread access to lifesaving treatments. Manufacturing Brighter Futures in Cell and Gene Therapy.”

Company website: http://www.oribiotech.com